Nuvectis Pharma, Inc.NVCTNASDAQ

Revenue (LTM)

Net Income (LTM)

$-26M

-39.2% YoY

Free Cash Flow

$-16M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-13	-19↓49.2%	-23↓19.0%	-20↑13.3%	-28↓38.9%
Net Income	-13	-19↓48.1%	-22↓16.6%	-19↑14.6%	-26↓39.2%
EBITDA	-13	-19↓49.2%	-23↓19.0%	-19↑17.0%	-28↓45.1%
EPS Diluted	-1.09	-1.51↓38.5%	-1.43↑5.3%	-1.11↑22.4%	-1.32↓18.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	6	20↑248.2%	19↓4.3%	19↓3.1%	32↑70.7%
Total Current Assets	6	20↑249.8%	19↓6.0%	19↓3.0%	32↑70.4%
Total Assets	7	20↑206.5%	19↓6.0%	19↓3.0%	32↑70.4%
Total Current Liabilities	2	6↑155.7%	7↑12.9%	9↑27.3%	13↑49.5%
Total Liabilities	18	6↓65.0%	7↑12.9%	9↑27.3%	13↑49.5%
Total Equity	-11	14↑229.2%	12↓14.2%	10↓20.4%	18↑89.6%
Total Debt	0	0	0	0	0
Net Debt	-6	-20↓248.2%	-19↑4.3%	-19↑3.1%	-32↓70.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-10	-14↓42.7%	-16↓17.7%	-12↑23.2%	-16↓30.7%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-10	-14↓42.7%	-16↓17.7%	-12↑23.2%	-16↓30.7%
Stock-Based Comp	2	2↓9.8%	5↑175.6%	5↑3.3%	1↓72.2%
Net Change in Cash	6	14↑148.2%	-1↓106.1%	-1↑31.6%	13↑2309.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance